SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $376K of Sight Sciences, Inc.
Bought$376,429
$3.81Price
98,782Shares
+1%Stake
What SGHT did for a copier
- $1,000 copied at Wed, Jun 4 open, $4.05
- $864
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Jul 18 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −5.1% against the S&P 500, and 3 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, May 30. Filed Tue, Jun 3, 9:57 PM ET, after the close. Returns use the Jun 4 open and the Jul 18 close. Not investment advice.